ArticleBMC cancer2025
Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fine-Needle Aspiration (FNA) has been routinely used for papillary thyroid carcinoma (PTC) diagnosis. One single liquid based tissue sample collected from FNA can be used for both cytological diagnosis and genetic testing at the same time. BRAF V600E mutation exhibits 100% specificity and high sensitivity for papillary thyroid carcinoma (PTC). However, FNA based studies on the genotypic (BRAF V600E) and ultrasonic (US) imaging characteristics (location and diameter) are exceedingly rare. Here, we aimed to study the genotypic (BRAF V600E) and US imaging characteristics (location and diameter) in a large retrospective cohort. A total of 4808 patients with thyroid nodules from a tertiary center underwent FNA, and 2430 patients underwent molecular testing. Our data demonstrated that the thyroid nodules were predominantly located on the right side (p = 0.0004). Patients diagnosed with Bethesda VI cytology had significantly more right-sided thyroid nodules (p = 0.0041). Interestingly, among patients with PTC with lymph node metastasis (LNM), right-side-affected LNM was significantly more common than left-side-affected LNM, which implies a biased regional LNM of right-side-located thyroid nodules (p = 0.0007). The size of BRAF-V600E mutated or right-lobe located nodules was significantly larger than that in the control group (p = 0.0156), and patients with a BRAF V600E mutation were considerably younger than those with wild-type BRAF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.